FDA grants orphan drug designation to ADV7103 for cystinuria
FDA grants orphan drug designation to ADV7103 for cystinuria Read Original Story Here The FDA has granted an orphan drug designation (ODD) to ADV7103 for the treatment of patients with cystinuria, according to a news release from Advicenne, the developer of the therapy.1 ADV7103 was also granted an ODD status by the FDA in [...]